Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Trim39 regulates neuronal apoptosis by acting as a SUMO-targeted E3 ubiquitin-ligase for the transcription factor NFATc3

Cell Death & Differentiation volume 29, pages 2107–2122 (2022)Cite this article

Subjects

Abstract

NFATc3 is the predominant member of the NFAT family of transcription factors in neurons, where it plays a pro-apoptotic role. Mechanisms controlling NFAT protein stability are poorly understood. Here we identify Trim39 as an E3 ubiquitin-ligase of NFATc3. Indeed, Trim39 binds and ubiquitinates NFATc3 in vitro and in cells where it reduces NFATc3 protein level and transcriptional activity. In contrast, silencing of endogenous Trim39 decreases NFATc3 ubiquitination and increases its activity, thereby resulting in enhanced neuronal apoptosis. We also show that Trim17 inhibits Trim39-mediated ubiquitination of NFATc3 by reducing both the E3 ubiquitin-ligase activity of Trim39 and the NFATc3/Trim39 interaction. Moreover, we identify Trim39 as a new SUMO-targeted E3 ubiquitin-ligase (STUbL). Indeed, mutation of SUMOylation sites in NFATc3 or SUMO-interacting motifs in Trim39 reduces NFATc3/Trim39 interaction and Trim39-induced ubiquitination of NFATc3. In addition, Trim39 preferentially ubiquitinates SUMOylated forms of NFATc3 in vitro. As a consequence, a SUMOylation-deficient mutant of NFATc3 exhibits increased stability and pro-apoptotic activity in neurons. Taken together, these data indicate that Trim39 modulates neuronal apoptosis by acting as a STUbL for NFATc3.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Fig. 1: Trim39 interacts with both Trim17 and NFATc3.
Fig. 2: Trim39 is an E3 ubiquitin-ligase of NFATc3.
Fig. 3: Trim39 mediates NFATc3 degradation.
Fig. 4: Trim17 inhibits TRIM39-mediated ubiquitination of NFATc3.
Fig. 5: Trim17 reduces the interaction between endogenous Trim39 and NFATc3.
Fig. 6: SUMOylation of NFATc3 favors its ubiquitination and stability.
Fig. 7: Trim39 is a SUMO-targeted E3 ubiquitin-ligase for NFATc3.
Fig. 8: SUMOylation and Trim39 attenuate NFATc3 pro-apoptotic effect in neurons.

Data availability

The data used during the current study are available from the corresponding author on reasonable request.

References

  1. Fric J, Zelante T, Wong AYW, Mertes A, Yu H-B, Ricciardi-Castagnoli P. NFAT control of innate immunity. Blood. 2012;120:1380–9.

    Article  CAS  PubMed  Google Scholar 

  2. Kipanyula MJ, Kimaro WH, Seke Etet PF. The emerging roles of the calcineurin-nuclear factor of activated T-lymphocytes pathway in nervous system functions and diseases. J Aging Res. 2016;2016:5081021.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Mognol GP, Carneiro FRG, Robbs BK, Faget DV, Viola JPB. Cell cycle and apoptosis regulation by NFAT transcription factors: new roles for an old player. Cell Death Dis. 2016;7:e2199.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Wu H, Peisley A, Graef IA, Crabtree GR. NFAT signaling and the invention of vertebrates. Trends Cell Biol. 2007;17:251–60.

    Article  CAS  PubMed  Google Scholar 

  5. Müller MR, Rao A. NFAT, immunity and cancer: a transcription factor comes of age. Nat Rev Immunol. 2010;10:645–56.

    Article  PubMed  Google Scholar 

  6. Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell. 2005;20:539–50.

    Article  CAS  PubMed  Google Scholar 

  7. Singh SK, Baumgart S, Singh G, Konig AO, Reutlinger K, Hofbauer LC, et al. Disruption of a nuclear NFATc2 protein stabilization loop confers breast and pancreatic cancer growth suppression by zoledronic acid. J Biol Chem. 2011;286:28761–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Youn M-Y, Yokoyama A, Fujiyama-Nakamura S, Ohtake F, Minehata K, Yasuda H, et al. JMJD5, a Jumonji C (JmjC) domain-containing protein, negatively regulates osteoclastogenesis by facilitating NFATc1 protein degradation. J Biol Chem. 2012;287:12994–3004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Li X, Wei W, Huynh H, Zuo H, Wang X, Wan Y. Nur77 prevents excessive osteoclastogenesis by inducing ubiquitin ligase Cbl-b to mediate NFATc1 self-limitation. Elife. 2015;4:e07217.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Narahara S, Sakai E, Kadowaki T, Yamaguchi Y, Narahara H, Okamoto K, et al. KBTBD11, a novel BTB-Kelch protein, is a negative regulator of osteoclastogenesis through controlling Cullin3-mediated ubiquitination of NFATc1. Sci Rep. 2019;9:3523.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Chao C-N, Lai C-H, Badrealam KF, Lo J-F, Shen C-Y, Chen C-H, et al. CHIP attenuates lipopolysaccharide-induced cardiac hypertrophy and apoptosis by promoting NFATc3 proteasomal degradation. J Cell Physiol. 2019;234:20128–38.

    Article  CAS  PubMed  Google Scholar 

  12. Terui Y, Saad N, Jia S, McKeon F, Yuan J. Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1. J Biol Chem. 2004;279:28257–65.

    Article  CAS  PubMed  Google Scholar 

  13. Nayak A, Glockner-Pagel J, Vaeth M, Schumann JE, Buttmann M, Bopp T, et al. Sumoylation of the transcription factor NFATc1 leads to its subnuclear relocalization and interleukin-2 repression by histone deacetylase. J Biol Chem. 2009;284:10935–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Vihma H, Timmusk T. Sumoylation regulates the transcriptional activity of different human NFAT isoforms in neurons. Neurosci Lett. 2017;653:302–7.

    Article  CAS  PubMed  Google Scholar 

  15. Kim ET, Kwon KM, Lee MK, Park J, Ahn J-H. Sumoylation of a small isoform of NFATc1 is promoted by PIAS proteins and inhibits transactivation activity. Biochem Biophys Res Commun. 2019;513:172–8.

    Article  CAS  PubMed  Google Scholar 

  16. Zhao X. SUMO-mediated regulation of nuclear functions and signaling processes. Mol Cell. 2018;71:409–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Henley JM, Carmichael RE, Wilkinson KA. Extranuclear SUMOylation in neurons. Trends Neurosci. 2018;41:198–210.

    Article  CAS  PubMed  Google Scholar 

  18. Liebelt F, Vertegaal ACO. Ubiquitin-dependent and independent roles of SUMO in proteostasis. Am J Physiol Cell Physiol. 2016;311:C284–296.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Geoffroy MC, Hay RT. An additional role for SUMO in ubiquitin-mediated proteolysis. Nat Rev Mol Cell Biol. 2009;10:564–8.

    Article  CAS  PubMed  Google Scholar 

  20. Prudden J, Pebernard S, Raffa G, Slavin DA, Perry JJP, Tainer JA, et al. SUMO-targeted ubiquitin ligases in genome stability. EMBO J. 2007;26:4089–101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Sriramachandran AM, Dohmen RJ. SUMO-targeted ubiquitin ligases. Biochim Biophys Acta. 2014;1843:75–85.

    Article  CAS  PubMed  Google Scholar 

  22. Ulrich JD, Kim MS, Houlihan PR, Shutov LP, Mohapatra DP, Strack S, et al. Distinct activation properties of the nuclear factor of activated T-cells (NFAT) isoforms NFATc3 and NFATc4 in neurons. J Biol Chem. 2012;287:37594–609.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Luo J, Sun L, Lin X, Liu G, Yu J, Parisiadou L, et al. A calcineurin- and NFAT-dependent pathway is involved in α-synuclein-induced degeneration of midbrain dopaminergic neurons. Hum Mol Genet. 2014;23:6567–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Mojsa B, Mora S, Bossowski JP, Lassot I, Desagher S. Control of neuronal apoptosis by reciprocal regulation of NFATc3 and Trim17. Cell Death Differ. 2015;22:274–86.

    Article  CAS  PubMed  Google Scholar 

  25. Caraveo G, Auluck PK, Whitesell L, Chung CY, Baru V, Mosharov EV, et al. Calcineurin determines toxic versus beneficial responses to α-synuclein. PNAS. 2014;111:E3544–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Lassot I, Mora S, Lesage S, Zieba BA, Coque E, Condroyer C, et al. The E3 ubiquitin ligases TRIM17 and TRIM41 modulate α-synuclein expression by regulating ZSCAN21. Cell Rep. 2018;25:2484–96. e9

    Article  CAS  PubMed  Google Scholar 

  27. Lionnard L, Duc P, Brennan MS, Kueh AJ, Pal M, Guardia F, et al. TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1. Cell Death Differ. 2019;26:902–17.

    Article  CAS  PubMed  Google Scholar 

  28. Rolland T, Taşan M, Charloteaux B, Pevzner SJ, Zhong Q, Sahni N, et al. A proteome-scale map of the human interactome network. Cell. 2014;159:1212–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Rual J-F, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature. 2005;437:1173–8.

    Article  CAS  PubMed  Google Scholar 

  30. Woodsmith J, Jenn RC, Sanderson CM. Systematic analysis of dimeric E3-RING interactions reveals increased combinatorial complexity in human ubiquitination networks. Mol Cell Proteom. 2012;11:M111.016162.

    Article  Google Scholar 

  31. Lassot I, Robbins I, Kristiansen M, Rahmeh R, Jaudon F, Magiera MM, et al. Trim17, a novel E3 ubiquitin-ligase, initiates neuronal apoptosis. Cell Death Differ. 2010;17:1928–41.

    Article  CAS  PubMed  Google Scholar 

  32. Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem. 2001;70:503–33.

    Article  CAS  PubMed  Google Scholar 

  33. Rodriguez MS, Dargemont C, Hay RT. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem. 2001;276:12654–9.

    Article  CAS  PubMed  Google Scholar 

  34. He X, Riceberg J, Soucy T, Koenig E, Minissale J, Gallery M, et al. Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor. Nat Chem Biol. 2017;13:1164–71.

    Article  CAS  PubMed  Google Scholar 

  35. Kerscher O. SUMO junction-what’s your function? New insights through SUMO-interacting motifs. EMBO Rep. 2007;8:550–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Zhao Q, Xie Y, Zheng Y, Jiang S, Liu W, Mu W, et al. GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs. Nucleic Acids Res. 2014;42:W325–330.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Beauclair G, Bridier-Nahmias A, Zagury J-F, Saïb A, Zamborlini A. JASSA: a comprehensive tool for prediction of SUMOylation sites and SIMs. Bioinformatics. 2015;31:3483–91.

    Article  CAS  PubMed  Google Scholar 

  38. Contestabile A. Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro. Cerebellum. 2002;1:41–55.

    Article  CAS  PubMed  Google Scholar 

  39. Ristic M, Brockly F, Piechaczyk M, Bossis G. Detection of protein-protein interactions and posttranslational modifications using the proximity ligation assay: application to the study of the SUMO pathway. Methods Mol Biol. 2016;1449:279–90.

    Article  CAS  PubMed  Google Scholar 

  40. Kim JH, Kim K, Jin HM, Song I, Youn BU, Lee SH, et al. Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1. J Biol Chem. 2010;285:5224–31.

    Article  CAS  PubMed  Google Scholar 

  41. Meroni G, Diez-Roux G. TRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases. Bioessays. 2005;27:1147–57.

    Article  CAS  PubMed  Google Scholar 

  42. Esposito D, Koliopoulos MG, Rittinger K. Structural determinants of TRIM protein function. Biochem Soc Trans. 2017;45:183–91.

    Article  CAS  PubMed  Google Scholar 

  43. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, et al. The tripartite motif family identifies cell compartments. EMBO J. 2001;20:2140–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Li Y, Wu H, Wu W, Zhuo W, Liu W, Zhang Y, et al. Structural insights into the TRIM family of ubiquitin E3 ligases. Cell Res. 2014;24:762–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Napolitano LM, Meroni G. TRIM family: Pleiotropy and diversification through homomultimer and heteromultimer formation. IUBMB Life. 2012;64:64–71.

    Article  CAS  PubMed  Google Scholar 

  46. Sanchez JG, Okreglicka K, Chandrasekaran V, Welker JM, Sundquist WI, Pornillos O. The tripartite motif coiled-coil is an elongated antiparallel hairpin dimer. Proc Natl Acad Sci USA. 2014;111:2494–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Koliopoulos MG, Esposito D, Christodoulou E, Taylor IA, Rittinger K. Functional role of TRIM E3 ligase oligomerization and regulation of catalytic activity. EMBO J. 2016;35:1204–18.

  48. Fiorentini F, Esposito D, Rittinger K. Does it take two to tango? RING domain self-association and activity in TRIM E3 ubiquitin ligases. Biochem Soc Trans. 2020;48:2615–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Streich FC, Ronchi VP, Connick JP, Haas AL. Tripartite motif ligases catalyze polyubiquitin chain formation through a cooperative allosteric mechanism. J Biol Chem. 2013;288:8209–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Yudina Z, Roa A, Johnson R, Biris N, de Souza Aranha Vieira DA, Tsiperson V, et al. RING dimerization links higher-order assembly of TRIM5α to synthesis of K63-linked polyubiquitin. Cell Rep. 2015;12:788–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Basu-Shrivastava M, Kozoriz A, Desagher S, Lassot I. To ubiquitinate or not to ubiquitinate: TRIM17 in cell life and death. Cells. 2021;10:1235.

  52. Bailey D, O’Hare P. Comparison of the SUMO1 and ubiquitin conjugation pathways during the inhibition of proteasome activity with evidence of SUMO1 recycling. Biochem J. 2005;392:271–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Uzunova K, Göttsche K, Miteva M, Weisshaar SR, Glanemann C, Schnellhardt M, et al. Ubiquitin-dependent proteolytic control of SUMO conjugates. J Biol Chem. 2007;282:34167–75.

    Article  CAS  PubMed  Google Scholar 

  54. Jansen NS, Vertegaal ACO. A chain of events: regulating target proteins by SUMO polymers. Trends Biochem Sci. 2021;46:113–23.

    Article  CAS  PubMed  Google Scholar 

  55. Parker JL, Ulrich HD. A SUMO-interacting motif activates budding yeast ubiquitin ligase Rad18 towards SUMO-modified PCNA. Nucleic Acids Res. 2012;40:11380–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Erker Y, Neyret-Kahn H, Seeler JS, Dejean A, Atfi A, Levy L. Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation. Mol Cell Biol. 2013;33:2163–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Abed M, Barry KC, Kenyagin D, Koltun B, Phippen TM, Delrow JJ, et al. Degringolade, a SUMO-targeted ubiquitin ligase, inhibits Hairy/Groucho-mediated repression. EMBO J. 2011;30:1289–301.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Boutell C, Cuchet-Lourenço D, Vanni E, Orr A, Glass M, McFarlane S, et al. A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence. PLoS Pathog. 2011;7:e1002245.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Wang L, Oliver SL, Sommer M, Rajamani J, Reichelt M, Arvin AM. Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin. PLoS Pathog. 2011;7:e1002157.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Zhang L, Mei Y, Fu NY, Guan L, Xie W, Liu HH, et al. TRIM39 regulates cell cycle progression and DNA damage responses via stabilizing p21. Proc Natl Acad Sci USA. 2012;109:20937–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Zhang L, Huang NJ, Chen C, Tang W, Kornbluth S. Ubiquitylation of p53 by the APC/C inhibitor Trim39. Proc Natl Acad Sci USA. 2012;109:20931–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Lee SS, Fu NY, Sukumaran SK, Wan KF, Wan Q, Yu VC. TRIM39 is a MOAP-1-binding protein that stabilizes MOAP-1 through inhibition of its poly-ubiquitination process. Exp Cell Res. 2009;315:1313–25.

    Article  CAS  PubMed  Google Scholar 

  63. Huang NJ, Zhang L, Tang W, Chen C, Yang CS, Kornbluth S. The Trim39 ubiquitin ligase inhibits APC/CCdh1-mediated degradation of the Bax activator MOAP-1. J Cell Biol. 2012;197:361–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Magiera MM, Mora S, Mojsa B, Robbins I, Lassot I, Desagher S. Trim17-mediated ubiquitination and degradation of Mcl-1 initiate apoptosis in neurons. Cell Death Differ. 2013;20:281–92.

    Article  CAS  PubMed  Google Scholar 

  65. Song K-H, Choi CH, Lee H-J, Oh SJ, Woo SR, Hong S-O, et al. HDAC1 upregulation by NANOG promotes multidrug resistance and a stem-like phenotype in immune edited tumor cells. Cancer Res. 2017;77:5039–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Bossis G, Chmielarska K, Gartner U, Pichler A, Stieger E, Melchior F. A fluorescence resonance energy transfer-based assay to study SUMO modification in solution. Methods Enzymol. 2005;398:20–32.

    Article  CAS  PubMed  Google Scholar 

  67. Brockly F, Piechaczyk M, Bossis G. Production and purification of recombinant SUMOylated proteins using engineered bacteria. Methods Mol Biol. 2016;1475:55–65.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This article is based upon work from COST Action (PROTEOSTASIS BM1307), supported by COST (European Cooperation in Science and Technology). We would like to thank the staff of the Montpellier Genomic Collection platform for providing human TRIM39 and human TRIM17 cDNA clones. We acknowledge the imaging facility MRI (Montpellier Ressources Imagerie), member of the national infrastructure France-BioImaging infrastructure supported by the French National Research Agency (ANR-10-INBS-04, “Investments for the future”). We are grateful to Frédérique Brockly for the production and purification of recombinant proteins and Dr Olivier Coux for providing ubiquitin mutants. We thank Drs Dimitris Liakopoulos and Manuel Rodriguez for interesting discussions.

Funding

This work was supported by the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Santé et de la Recherche Médicale (INSERM), the Université de Montpellier, La Fondation de l’Association pour la Recherche contre le Cancer (ARC, grant number PJA 20141201882 to SD), La Ligue contre le Cancer (grant number TDUM13665 to BM) and La Fondation pour la Recherche Médicale (grant number FDT201904008340 to MBS).

Author information

Authors and Affiliations

  1. IGMM, Univ Montpellier, CNRS, Montpellier, France

    Meenakshi Basu-Shrivastava, Barbara Mojsa, Stéphan Mora, Ian Robbins, Guillaume Bossis, Iréna Lassot & Solange Desagher

  2. Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, MA, USA

    Meenakshi Basu-Shrivastava

  3. Centre for Gene Regulation and Expression, School of Life Science, University of Dundee, Dundee, UK

    Barbara Mojsa

Authors
  1. Meenakshi Basu-Shrivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara Mojsa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stéphan Mora
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ian Robbins
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guillaume Bossis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Iréna Lassot
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Solange Desagher
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MBS, BM and IL designed and performed experiments, and analyzed the data; SM performed experiments; SD and BM conceived the study; SD performed the statistical analysis, wrote and revised the manuscript, and prepared the figures; IR cloned Trim39 and reviewed the manuscript; GB provided material support and contributed in the design of experiments.

Corresponding author

Correspondence to Solange Desagher.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Edited by M Piacentini

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Basu-Shrivastava, M., Mojsa, B., Mora, S. et al. Trim39 regulates neuronal apoptosis by acting as a SUMO-targeted E3 ubiquitin-ligase for the transcription factor NFATc3. Cell Death Differ 29, 2107–2122 (2022). https://doi.org/10.1038/s41418-022-01002-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41418-022-01002-2

Search

Advanced search

Quick links